July 2023 updates to the website
20 July 2023
The website has now been updated following July's LSCMMG
The following guidelines have been added/updated:
Nutritional Supplements Post Bariatric Surgery
Algorithm For Antihyperglycaemic Therapy in Adults with Type 2 Diabetes
Lipid Management Guidance for Secondary Prevention of CVD
The following Items will be updated following the next ICB approval meeting:
NICE TA 902 Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
NICE TA 905 Upadacitinib for previously treated moderately to severely active Crohn’s disease
NICE TA 907 Deucravacitinib for treating moderate to severe plaque psoriasis